Zachary Warren, Ph. D.
Professor of Pediatrics, Psychiatry, and Behavioral Sciences, Vanderbilt University Medical Center;
Executive Director of Treatment and Research Institute on Autism Spectrum Disorders, Vanderbilt Kennedy Center

Dr. Warren received a Ph.D. in Clinical Psychology in 2005 from the University of Miami and is currently a Professor of Pediatrics, Psychiatry and Behavioral Sciences, and Special Education at Vanderbilt University Medical Center (VUMC). He is the Endowed Executive Director of the Vanderbilt Kennedy Center’s (VKC) Treatment and Research Institute on Autism Spectrum Disorders (TRIAD), Director of the Division of Developmental Medicine at Vanderbilt Children’s Hospital, and Director of Autism Research for the VKC and the Department of Pediatrics. His current research focuses on early detection and intervention for ASD as well as in the application of telehealth for enhanced identification and service.  Dr. Warren has received funding and support from AHRQ, Autism Speaks, CDC, HRSA/MCH, NICHD, NIMH, NSF, the Simons Foundation, and other agencies.  He is seen as a national and international leader regarding ASD screening/diagnosis and treatment.  For the past 15 years, he has been collaborating with members of the Vanderbilt University School of Engineering (VUSE) on projects aimed at developing and testing intelligent technologies for use in ASD assessment and intervention.  He is presently Deputy Director of the Frist Center for Autism and Innovation and collaborating on NSF, IES, and NIMH supported projects refining technological systems for lifespan support.  Dr. Warren also oversees the large professional development structures that are part of TRIAD which are funded to provide evidence-based training for ASD service and professional capacity building across the state of Tennessee through the Department of Education, Department of Intellectual and Developmental Disabilities, the Tennessee Early Intervention System (TEIS), and affiliated pediatric care settings.  Dr. Warren has spent the past 6 years spearheading some of the first studies examining the use of telehealth for ASD diagnosis, including conceptualization, development, and implementation of the Tele-ASD-Peds and ongoing funded trials.